<?xml version='1.0' encoding='ISO-8859-1'?>
<xml>
<title>Illinois General Assembly - Bill Status for HB 4421         </title>
<shortdesc>INS CD-BREAST TOMOSYNTHESIS</shortdesc>
<sponsor>
<sponsorhead1>House Sponsors</sponsorhead1><sponsors>Rep. Janet Yang Rohr-Natalie A. Manley-Anne Stava-Murray-Dagmara Avelar-Camille Y. Lilly, Katie Stuart, Anna Moeller, Laura Faver Dias, Maura Hirschauer, Jenn Ladisch Douglass, Norma Hernandez, Mary Gill, Sharon Chung and Kimberly Du Buclet</sponsors>
</sponsor>
<lastaction>
<statusdate>1/7/2025</statusdate><chamber>House</chamber><action>Session Sine Die</action>
</lastaction>
<synopsis>
<synopsistitle></synopsistitle>
<reference>215 ILCS 5/356g</reference><aliasreference>from Ch. 73, par. 968g</aliasreference><SynopsisText>     Amends the Illinois Insurance Code. In a provision concerning coverage for mammograms, provides that if a woman's physician has ordered the patient to receive breast tomosynthesis because it has been determined that high breast density will make low-dose mammography inaccurate or ineffective, the insurer shall not require the physician to order an additional low-dose mammography as a precondition to breast tomosynthesis, nor shall an insurer require the patient to receive a low-dose mammography as a precondition to breast tomosynthesis. Provides that if the results of a woman's first 2-dimensional mammogram screening determine that the patient has high breast density, coverage of breast tomosynthesis shall be provided at no cost to the insured, regardless of whether the breast tomosynthesis and 2-dimensional mammogram occurs within the same calendar year, coverage year, or 365-day period.</SynopsisText></synopsis>
<actions>
<statusdate>1/10/2024</statusdate><chamber>House</chamber><action>Filed with the Clerk by Rep. Janet Yang Rohr</action>
<statusdate>1/16/2024</statusdate><chamber>House</chamber><action>First Reading</action>
<statusdate>1/16/2024</statusdate><chamber>House</chamber><action>Referred to Rules Committee</action>
<statusdate>2/14/2024</statusdate><chamber>House</chamber><action>Assigned to Insurance Committee</action>
<statusdate>3/6/2024</statusdate><chamber>House</chamber><action>Added Chief Co-Sponsor Rep. Natalie A. Manley</action>
<statusdate>3/6/2024</statusdate><chamber>House</chamber><action>Added Chief Co-Sponsor Rep. Anne Stava-Murray</action>
<statusdate>3/6/2024</statusdate><chamber>House</chamber><action>Added Chief Co-Sponsor Rep. Dagmara Avelar</action>
<statusdate>3/6/2024</statusdate><chamber>House</chamber><action>Added Chief Co-Sponsor Rep. Camille Y. Lilly</action>
<statusdate>3/6/2024</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Katie Stuart</action>
<statusdate>3/6/2024</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Anna Moeller</action>
<statusdate>3/6/2024</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Laura Faver Dias</action>
<statusdate>3/6/2024</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Maura Hirschauer</action>
<statusdate>3/6/2024</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Jenn Ladisch Douglass</action>
<statusdate>3/6/2024</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Norma Hernandez</action>
<statusdate>3/6/2024</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Mary Gill</action>
<statusdate>3/6/2024</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Sharon Chung</action>
<statusdate>3/6/2024</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Kimberly Du Buclet</action>
<statusdate>4/5/2024</statusdate><chamber>House</chamber><action>Rule 19(a) / Re-referred to Rules Committee</action>
<statusdate>1/7/2025</statusdate><chamber>House</chamber><action>Session Sine Die</action>
</actions>
</xml>

